Gene · 85340
KRT90P: keratin 90, pseudogene
12 sourcesgene-search-2026-11-11-0.2.0
Download JSON
Cite this record
ConductScience Library. KRT90P: keratin 90, pseudogene. Genes, record 85340. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/85340
On this page
Gene
Proteins0
Reviewed human proteins whose Swiss-Prot entry states the gene.
None in this release.
Patents0
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
None in this release.
Drugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,373
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | KRT90P papers | Newest fiscal year |
|---|---|---|---|
| R01HL119479 | Regulation of Hemoglobin Switching | 12 | 2025 |
| U54DK106829 | Stem Cell and Transplantation Biology | 9 | 2025 |
| R01DK103794 | Systematic Genetic Dissection of Human Erythropoiesis | 8 | 2025 |
| P30CA021765 | Cancer Center Support Grant (CCSG) | 7 | 2025 |
| R01HL146442 | The role of ferroptosis in red cell aging in vivo and in vitro | 7 | 2025 |
| R01HL156647 | Base editing and prime editing for sickle cell disease | 7 | 2025 |
| R01HL161004 | The paradoxical response to iron in pulmonary hypertension of sickle cell disease | 6 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 5 | 2025 |
| T32HL007150 | Pediatric Hematology Research Training Program | 5 | 2025 |
| K08DK129716 | Cellular Signaling Pathways in the Regulation of Fetal Hemoglobin for Treatment of Sickle Cell Disease | 4 | 2025 |
1 to 10 of 1,373Source NIH's project files
See all 1,373 nih grantsPapers3,295
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Challenges in Glycemic Monitoring: Undetectable HbA1c Level in an Asymptomatic Patient With Hemoglobin E and Beta-Thalassemia Minor: A Case Report. | J ASEAN Fed Endocr Soc | 2026 | 42802820 | PubTator, text mining | PubMed |
| CRISPR-Based Mediated Reactivation of Fetal Hemoglobin as a Therapeutic Strategy for Hemoglobinopathies: Evidence from Preclinical to Clinical Trials in Sickle Cell Disease and β-Thalassemia. | Hemoglobin | 2026 | 42755327 | PubTator, text mining | PubMed |
| Gentamicin Targeting Human Hemoglobin Induces Methemoglobin Formation and Decreases Oxygen Affinity: A Molecular Mechanism of Hematologic Toxicity. | Int J Mol Sci | 2026 | 42737656 | PubTator, text mining | PubMed |
| Association Between Haemoglobin Variant Phenotypes and Red Blood Cell Parameters Among Pregnant Women: A Hospital-Based Cross-Sectional Study in Ghana. | Biomed Res Int | 2026 | 42720037 | PubTator, text mining | PubMed |
| Recombinant Hemoglobin rHb0.1 with Cross-Linked Alpha Subunits Preferentially Crystallizes in the β4 Oligomeric State, Potentially Driven by a βG18(H116I) Mutation. | ACS Omega | 2026 | 42719418 | PubTator, text mining | PubMed |
| A machine-learning capillary electrophoresis-based pattern to identify suspected sickle cell trait and α-thalassemia co-inheritance. | Adv Lab Med | 2026 | 42713326 | PubTator, text mining | PubMed |
| Evaluating HbA1c measurement in haemoglobinopathy patients: Is transition beyond HPLC warranted for improved clinical accuracy? | J Chromatogr B Analyt Technol Biomed Life Sci | 2026 | 42685568 | PubTator, text mining | PubMed |
| A structure and function-based complete mutational map of human hemoglobin using AI. | Front Chem | 2026 | 42661945 | PubTator, text mining | PubMed |
| Microcytic Anemia with Low HbA2 and Normal HbA: Two Cases of Rare Thalassemia. | Hemoglobin | 2026 | 42655983 | PubTator, text mining | PubMed |
| Genetic profiles and hematological characteristics of the α-Hb variant Hb Chumphae (HBA2:c.32T>A) in association with -SEA deletion α0-thalassemia. | Hematol Transfus Cell Ther | 2026 | 42526165 | PubTator, text mining | PubMed |
1 to 10 of 3,295
See all 3,295 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/85340
GET https://conductscience.org/api/genes/v1/85340/grants?page=2